GlassScriptPhysician profile
Cody Rowan
NPI 1013165331
$5,695.57
in general payments reported to CMS, 2019-2025
13 companies · $363 in 2025
The $363 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,368 · 2020: $120 · 2021: $473 · 2022: $2,289 · 2023: $577 · 2024: $506 · 2025: $363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,446.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,445.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,535.43 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Boston Scientific Corporation | $1,016.99 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Nevro Corp. | $748.30 | 2019-2024 | Senza |
| Medtronic USA, INC. | $734.40 | 2019 | |
| Abbott Laboratories | $292.05 | 2019 | |
| Spr Therapeutics, INC | $119.74 | 2021-2022 | |
| Curonix LLC | $97.95 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Averitas Pharma INC. | $46.48 | 2023 | Qutenza |
| Globus Medical, INC. | $24.21 | 2025 | Senza |
| Laborie Medical Technologies Corp. | $22.87 | 2024 | Endosheath Technology |
| Scilex Pharmaceuticals INC. | $22.83 | 2022 | |
| Collegium Pharmaceutical, INC. | $19.38 | 2023 | Belbuca |
| Valinor Pharma, LLC | $14.94 | 2025 | Movantik |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cody Rowan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.